Investor Relations

Here you will find details on our share as well as detailed information on key figures, annual and quarterly results, IR events and much more.

2018: IFRS results

HAEMATO AG achieved consolidated sales of EUR 274.1m, an operating result (EBIT) of EUR 8.5m and net profit of EUR 6.3m in the 2018 financial year, taking into account IFRS 15 “Revenues”,
which must be applied from the 2018 financial year onwards.
A capital increase of EUR 5.2m to replace profit participation certificates improved the equity ratio from 57.2% (2017) to 65.0% in 2018 and contributed, among other things, to a significant reduction in financial liabilities by a total of EUR 10.9m.



Net Income


Equity Ratio


Get information about the HAEMATO AG share and get an overview of the current price development.

Rating & Research

Here you will find well-founded stock analyses of renowned research houses and banks on the HAEMATO AG share.

BUY: 6.00 €

GBC AG, 4 September 2019

BUY: 4.80 €

Berlin Equity Research, 9 September 2019

BUY: 6.15 €

Berlin Equity Research, 27 May 2019


Lilienthalstraße 5c
12529 Schönefeld

Phone: +49-30 897 30 86 70
Telefax: +49-30 897 30 86 79